Protecting patients from harm: Terfenadine and potential drug therapy interactions

Drug Information Journal

Volumn 32, Issue 2, 1998, Pages 339-345

  Morris, Lisa Stockwell ^a  

^a IMS America   (United States)

Author keywords

Contraindicated drugs; Drug drug interactions; Medication errors; Patient counseling; Terfenadine

Indexed keywords

ASTEMIZOLE; CETIRIZINE; ENALAPRIL MALEATE; FEXOFENADINE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; IMIDAZOLE DERIVATIVE; ITRACONAZOLE; KETOCONAZOLE; LORATADINE; MACROLIDE; MESTRANOL PLUS NORETHISTERONE; RIFAMPICIN; TERFENADINE;

ALLERGY; DRUG CONTRAINDICATION; DRUG INFORMATION; DRUG MARKETING; DRUG MIXTURE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; HUMAN; LIVER DYSFUNCTION; PATIENT COUNSELING; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; TORSADE DES POINTES;

EID: 0031802297     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159803200203     Document Type: Review

References (19)

1. Masheter HC. Terfenadine: the first nonsedating antihistamine. Clin Rev Allergy. 1993;ll:5-34.
2. Mathews DR, McNutt B, Okerholm R, Hicker M, McBride G. Torsades de pointes occurring in association with terfenadine use. JAMA. 1991;266:2375-2376.
3. Zechnich AD, Hedges JR, Eiselt-Proteau D, Haxby D. Possible interactions with terfenadine or astemizole. Western J Med. 1994;160:321-325.
4. Cavuto JM, Woosley RL, Sale M. Pharmacies and prevention of potentially fatal drug interactions. JAMA. 1996;275(14):1086.
5. Carlson AM, Morris LS. Co-prescription of terfenadine and erythromycin or ketoconazole: an assessment of potential harm. J Am Phanna Assoc. 1996; NS36(4):263-269.
6. Thompson D, Oster G. Use of terfenadine and contraindicated drugs. JAMA. 1996;275(17):1339-1341.
7. Pink Sheet. Seldane overlapping use with contraindicated drugs declined from 5.4% to 2.3%. F-D-C Reports. May 6, 1996:T & G 8.
8. MedWatch. Recent safety information on FDAregulated products. PDA Medical Bulletin. 1996; 26(3):5.
9. Colbum D. Warning: Seldane + popular antibiotic = trouble. Despite labels, patients may still receive a potentially deadly combination. Washington Post Health. April 16, 1996.
10. Wu C. Newswatch: Allergy sufferers who use the prescription antihistamine Seldane should be wary of more than just the spring air. US Nen's and World Report. April 29, 1996:82.
11. Headden S, Lenzy T, et al. Danger at the drug store. US News and World Report. August 26,1996:47-51.
12. Zoeller J. News analysis: US News article pummels pharmacists. Am Druggist. September 1996:8, 11.
13. Susman E. Dispensing danger. Retail Phar News. September 1996:8.
14. Federal Register. Proposal to withdraw approval of two new drug applications and one abbreviated new drug application; opportunity for a hearing. Food and Drug Administration [Docket No. 96N-0512]. Federal Register. 1997;62(9):2-9.
15. Ono Y. Drug makers try to win over Seldane users. Wall Street Journal. January 31, 1997:Bl-2.
16. Bates DW, Leape LL. Commentary. JAMA. 1996; 275(14):1086-1087.
17. Roberts JS, Watrous ML, Schulz RM, et al. Quantifying the clinical significance of drug-drug interac-lions: scaling pharmacists' perceptions of a common interaction classification scheme. Ann Pharmacother. 1996;30(9):926-933.
18. Vivian JC. Liability for a drug-drug interaction. U.S. Pharmacist. June 1996:93-94.
19. Kraft KE, Dore FH. Computerized drug interaction programs: how reliable? JAMA. 1996;275(14): 1087.